New micromaterial releases nanoparticles that selectively destroy cancer cells

New micromaterial releases nanoparticles that selectively destroy cancer cells
Protein transit though secretory granules. Credit: Advanced Science (2024). DOI: 10.1002/advs.202309427

Researchers have developed micromaterials made up only of proteins, capable of delivering over an extended period of time nanoparticles that attack specific cancer cells and destroy them. The micromaterials mimic natural secretory granules found in the endocrine system and were proven effective in mouse models of colorectal cancer.

googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1449240174198-2’); });

The study is published in the journal Advanced Science.

A team coordinated by Professor Antonio Villaverde from the Institute of Biotechnology and Biomedicine of the Department of Genetics and Microbiology, UAB, and with the participation of the Sant Pau Research Institute and the CIBER-BBN, has developed self-contained micromaterials made up only of proteins that are capable of delivering over an extended period of time the polypeptide that composes them.

The technology used for the fabrication of these granules, patented by the researchers, is relatively simple and mimics the secretory granules of the human endocrine system. With regards to its chemical structure, it involves the coordination of ionic zinc with histidine-rich domain, an amino acid essential for living beings and therefore not toxic.

The new micromaterials developed by researchers are formed by chains of amino acids known as polypeptides, which are functional and bioavailable in the form of nanoparticles that can be released and targeted to specific types of cancer cells, for selective destruction.

The research team analyzed the molecular structure of these materials and the dynamics behind the secretion process, both in vitro and in vivo. In an animal model of CXCR4+ colorectal cancer, the system showed high performance upon subcutaneous administration, and how the released protein nanoparticles accumulated in tumor tissues.

“It is important to highlight that this accumulation is more efficient than when the protein is administered in blood. This fact offers an unexpected new way to ensure high local drug levels and better clinical efficacy, thus avoiding repeated intravenous administration regimens,” explains Professor Villaverde.

“In the clinical context, the use of these materials in the treatment of colorectal cancer should largely enhance drug efficiency and patient’s comfort, while at the same time minimizing undesired side effects.”

More information:
Julieta M. Sánchez et al, Structural Stabilization of Clinically Oriented Oligomeric Proteins During their Transit through Synthetic Secretory Amyloids, Advanced Science (2024). DOI: 10.1002/advs.202309427

Journal information:Advanced Science

Provided by
Autonomous University of Barcelona

READ MORE

New parity-time symmetric system opens up range of wavelengths to researchers, engineers

Credit: Pixabay/CC0 Public Domain Researchers from the labs of Lan Yang, the Edwin H. & [...]

How Operation Plowshare Worked

In the wake of World War II, scientists tested nuclear weapons in the hopes of [...]

Researchers tune nanowire properties with peptide ‘decorations’

Credit: CC0 Public Domain In the latest paper from the Geobacter Lab led by microbiologist [...]

Fast Forward: The Dark Energy Camera

/ Reidar Hahn Ever since the Big Bang nearly 14 billion years ago, the universe has [...]

Drinking Noncow’s Milk May Stunt Children’s Growth

Nondairy milk is a burgeoning industry in many countries, but it may be causing delays [...]

Nanoclusters self-organize into centimeter-scale hierarchical assemblies

Credit: Pixabay/CC0 Public Domain Nature may abhor a vacuum, but it sure loves structure. Complex, [...]

How Sleepy Are Sloths and Other Lessons Learned

Three-toed sloths are among the animal species studied by Smithsonian scientists in Panama. Oyvind Martinsen [...]